A new diketopiperazine-like inhibitor of bone morphogenetic protein-induced osteoblastic differentiation produced by marine-derived Aspergillus sp. BFM-0085
暂无分享,去创建一个
[1] Bin Yang,et al. Structurally diverse diketopiperazine alkaloids from the marine-derived fungus Aspergillus versicolor SCSIO 41016 , 2019, Organic Chemistry Frontiers.
[2] Y. Liu,et al. Protuboxepin C and protuboxepin D from the sponge-derived fungus Aspergillus sp SCSIO XWS02F40 , 2018, Natural product research.
[3] Y. Nakachi,et al. Recent Topics in Fibrodysplasia Ossificans Progressiva , 2018, Endocrinology and metabolism.
[4] S. Ohte,et al. Scopranones with Two Atypical Scooplike Moieties Produced by Streptomyces sp. BYK-11038. , 2017, Organic letters.
[5] K. Kawakami,et al. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. , 2017, The Journal of clinical investigation.
[6] A. Economides,et al. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1R206H Fibrodysplasia Ossificans Progressiva (FOP) Mutation , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Ke-Chun Liu,et al. Alkaloids with Cardiovascular Effects from the Marine-Derived Fungus Penicillium expansum Y32 , 2015, Marine drugs.
[8] Lily Huang,et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A , 2015, Science Translational Medicine.
[9] S. Ohte,et al. 5-Prenyltryptophol, a new inhibitor of bone morphogenetic protein-induced alkaline phosphatase expression in myoblasts, produced by Streptomyces colinus subsp. albescens HEK608 , 2014, The Journal of Antibiotics.
[10] F. Kaplan,et al. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis , 2012, Disease Models & Mechanisms.
[11] Y. Mishina,et al. Corrigendum: Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor–γ agonists , 2012, Nature Medicine.
[12] S. Ohte,et al. Trichocyalides A and B, new inhibitors of alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblasts, produced by Trichoderma sp. FKI-5513 , 2012, The Journal of Antibiotics.
[13] Yukihiro Asami,et al. Protuboxepin A, a marine fungal metabolite, inducing metaphase arrest and chromosomal misalignment in tumor cells. , 2012, Bioorganic & medicinal chemistry.
[14] S. Ohte,et al. Fungal pyrrolidine-containing metabolites inhibit alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblastoma cells , 2012 .
[15] Yukihiro Asami,et al. Protuboxepins A and B and protubonines A and B from the marine-derived fungus Aspergillus sp. SF-5044. , 2011, Journal of natural products.
[16] Masahiro Iwamoto,et al. Potent Inhibition of Heterotopic Ossification by Nuclear Retinoic Acid Receptor γ Agonists , 2011, Nature Medicine.
[17] Y. Okazaki,et al. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. , 2009, The Journal of biological chemistry.
[18] Tomokazu Fukuda,et al. BMP type I receptor inhibition reduces heterotopic ossification , 2008, Nature Medicine.
[19] In Ho Choi,et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva , 2006, Nature Genetics.
[20] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.